Cyxone AB Cash And Equivalents vs. Return On Equity

CYXO Stock  SEK 0.03  0  5.08%   
Based on the measurements of profitability obtained from Cyxone AB's financial statements, Cyxone AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Cyxone AB's ability to earn profits and add value for shareholders.
For Cyxone AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cyxone AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cyxone AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cyxone AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cyxone AB over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Cyxone AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyxone AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyxone AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cyxone AB Return On Equity vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cyxone AB's current stock value. Our valuation model uses many indicators to compare Cyxone AB value to that of its competitors to determine the firm's financial worth.
Cyxone AB is rated second in cash and equivalents category among its peers. It also is rated second in return on equity category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyxone AB's earnings, one of the primary drivers of an investment's value.

Cyxone Return On Equity vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cyxone AB

Cash

 = 

Bank Deposits

+

Liquidities

 = 
56.34 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Cyxone AB

Return On Equity

 = 

Net Income

Total Equity

 = 
-1.07
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Cyxone Return On Equity Comparison

Cyxone AB is currently under evaluation in return on equity category among its peers.

Cyxone AB Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cyxone AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cyxone AB will eventually generate negative long term returns. The profitability progress is the general direction of Cyxone AB's change in net profit over the period of time. It can combine multiple indicators of Cyxone AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden.

Cyxone Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cyxone AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cyxone AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cyxone AB's important profitability drivers and their relationship over time.

Use Cyxone AB in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyxone AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyxone AB will appreciate offsetting losses from the drop in the long position's value.

Cyxone AB Pair Trading

Cyxone AB Pair Trading Analysis

The ability to find closely correlated positions to Cyxone AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyxone AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyxone AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyxone AB to buy it.
The correlation of Cyxone AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyxone AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyxone AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyxone AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Cyxone AB position

In addition to having Cyxone AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hotels Thematic Idea Now

Hotels
Hotels Theme
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Cyxone Stock Analysis

When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.